Using Patient Navigation to Promote Bowel Screening in AAA Attendees. (TET BETA)
Testing the Efficacy, Feasibility, Acceptability and Cost-effectiveness of Patient Navigation to Promote Bowel Cancer Screening Participation Among Non-responders Attending Abdominal Aortic Aneurysm (AAA) Screening: A Multi-centre Pilot Study.
The goal of this single-arm, multi-centre feasibility study is to assess the efficacy, feasibility and acceptability of implementing patient navigation across Abdominal Aortic Aneurysm (AAA) screening services in England to increase uptake of bowel cancer screening. The main questions it aims to answer are:
- Do service users complete a bowel cancer screening within three months of receiving patient navigation?
- Do service deliverers consider patient navigation as feasible to implement in practice?
- Do service users consider patient navigation acceptable to receive during their AAA appointment? Participants will be asked to discuss bowel screening with AAA practitioners (patient navigation). Follow-up surveys and interviews will be conducted with those that delivered the intervention and with those that received it.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
Bowel cancer is a leading cause of cancer-related mortality in England. Biennial Faecal Immunochemical Test (FIT) screening can reduce bowel cancer-related deaths by detecting cases before symptoms develop. However, uptake remains suboptimal, particularly among men. Evidence from a single-centre study in Scotland suggests that a brief intervention, akin to patient navigation, delivered to men attending routine abdominal aortic aneurysm (AAA) screening appointments, can facilitate participation.
The overarching aim of this study is to evaluate the efficacy, feasibility, acceptability and cost-effectiveness of implementing patient navigation intervention across AAA screening services in England.
This study will be a single-arm, multi-centre feasibility study that will be conducted across five AAA screening centres in England, i.e. Leicester, Birmingham and Black Country, London, West Yorkshire, and Somerset and North Devon. Over a three-month period (August-November 2026), AAA screening practitioners will deliver patient navigation to a sample of approximately 4190 men, aged 65+ years, who attend AAA screening and self-report as bowel screening non-responders.
The primary outcome of the study is completion of a FIT kit within three months of the AAA appointment. Secondary outcomes include the feasibility, acceptability and cost-effectiveness of the intervention.
The study comprises three Work Packages:
Work Package 1 will be the single-arm, multi-centre feasibility study. The outcome will be the completion of a bowel cancer screening kit, providing preliminary evidence of efficacy.
Work Package 2 will evaluate feasibility from the service provider perspective, using surveys (Workstream 2a) and interviews (Workstream 2b) with AAA service providers.
Work Package 3 will assess acceptability from the service user perspective, using surveys (Workstream 3a) and interviews (Workstream 3b) with those who received the intervention during the study period.
The findings will be used to inform an implementation toolkit as part of a national strategy to improve the uptake of bowel screening.
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前：Elizabeth Bailey
- 電話番号：+441483 300800
- メール：assurance@surrey.ac.uk
研究場所
-
-
-
Leicester、イギリス
- University Hospitals of Leicester NHS Trust
-
-
参加基準
適格基準
適格基準
就学可能な年齢
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Men aged 65 years and above
- Attending an AAA screening appointment
- Have not completed their most recent bowel screening
- Agree to discuss bowel screening further
Exclusion Criteria:
- Men aged <65years
- Those who do not attend their AAA screening appointment
- Have completed their most recent bowel screening
- Do not agree to discuss bowel screening further
- Those who received a positive AAA result in their appointment.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：ふるい分け
- 割り当て：なし
- 介入モデル：単一グループの割り当て
- マスキング：なし（オープンラベル）
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
他の：Patient Navigation
Eligibility: Men who have a negative AAA result, indicate that they have not completed their most recent bowel screening and are happy to discuss this further. Intervention: A 2 minute Patient Navigation intervention (discussion regarding barriers to completing bowel cancer screening) |
Brief 1.5-2 minute conversation to discuss barriers and solutions to why have not completed most recent bowel screening.
Offer of third party request or information to contact screening service.
|
この研究は何を測定していますか？
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Number of FIT test completed
時間枠：Completion within 3 months of patient navigation intervention
|
Completion of FIT test
|
Completion within 3 months of patient navigation intervention
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Feasibility of delivering patient navigation (survey)
時間枠：0-5 months post patient navigation delivery
|
Survey with those who delivered patient navigation.
Survey contains 7 items: 2 demographic questions, 2 items on a 3-point Likert scale (with option to provide further detail in open text), 2 open text responses, and one dichotomous item (Yes/No).
The Likert scales are scored where 1 is low and 3 is high.
|
0-5 months post patient navigation delivery
|
|
Feasibility of delivering patient navigation (Interviews)
時間枠：0-5 months post patient navigation delivery
|
Semi-structured interviews with those who delivered patient navigation
|
0-5 months post patient navigation delivery
|
|
Acceptability of receiving patient navigation (Survey)
時間枠：0-5 months post patient navigation
|
Survey with service users who received patient navigation.
Survey contains 12 items: 4 demographic questions, 5 items on a 5-point Likert scale, and 3 open text responses.
The Likert scales are scored where 1 is high and 5 is low.
|
0-5 months post patient navigation
|
|
Acceptability of receiving patient navigation (Interviews)
時間枠：0-5 months post patient navigation
|
Semi-structured interviews with service users who received patient navigation
|
0-5 months post patient navigation
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- 主任研究者：Robert Kerrison, PhD、University of Surrey
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- SPON 2026-06
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。